tiprankstipranks
Compass Therapeutics presents data on combination of CTX-009, CTX-471
PremiumThe FlyCompass Therapeutics presents data on combination of CTX-009, CTX-471
17d ago
Compass Therapeutics Presents Data Demonstrating Elimination of MHC Class I Negative Tumors in In Vivo Models at the 2024 American Association for Cancer Research (AACR) Annual Meeting
PremiumPress Releases
Compass Therapeutics Presents Data Demonstrating Elimination of MHC Class I Negative Tumors in In Vivo Models at the 2024 American Association for Cancer Research (AACR) Annual Meeting
17d ago
Compass Therapeutics Reports 2023 Financial Results and Provides Corporate Update
PremiumPress Releases
Compass Therapeutics Reports 2023 Financial Results and Provides Corporate Update
1M ago
Compass Therapeutics provides business update
PremiumThe FlyCompass Therapeutics provides business update
4M ago
Compass Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
PremiumPress Releases
Compass Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
6M ago
Compass Therapeutics reports Q3 EPS (8c) vs (12c) last year
PremiumThe Fly
Compass Therapeutics reports Q3 EPS (8c) vs (12c) last year
6M ago
Compass Therapeutics to be added to Russell 2000, 3000 Indexes June 26
PremiumThe FlyCompass Therapeutics to be added to Russell 2000, 3000 Indexes June 26
10M ago
Compass Therapeutics to be Added to the Russell 2000® and Russell 3000® Indexes
PremiumPress Releases
Compass Therapeutics to be Added to the Russell 2000® and Russell 3000® Indexes
10M ago
Compass Therapeutics to Participate in Upcoming Investor Events
PremiumPress Releases
Compass Therapeutics to Participate in Upcoming Investor Events
11M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100